1996
DOI: 10.4269/ajtmh.1996.55.482
|View full text |Cite
|
Sign up to set email alerts
|

The Evaluation of a Dipstick Test for Plasmodium falciparum in Mining Areas of Venezuela

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
1

Year Published

1999
1999
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 0 publications
0
12
1
Order By: Relevance
“…The OptiMAL test shows sensitivity similar to those reported for other dipsticks, such as ParaSight and ICT Malaria Pf/Pv, which ranged from 86-100 and 58-96%, respectively (3,20,(28)(29)(30)(31)(32)(33) Coleman et al (35) evaluated the efficacy of the ICT Malaria Pf/Pv in a large study of 559 asymptomatic patients from an endemic area of Thailand using conventional microscopy as the reference method, and found that the sensitivity for P. falciparum dropped from 100 to 23.3% when the parasitemia was below 500 trophozoites/µL. For P. vivax infections, the sensitivity dropped from 66.7% to 0 at parasitemia below 500 trophozoites/µL.…”
Section: Discussionmentioning
confidence: 55%
“…The OptiMAL test shows sensitivity similar to those reported for other dipsticks, such as ParaSight and ICT Malaria Pf/Pv, which ranged from 86-100 and 58-96%, respectively (3,20,(28)(29)(30)(31)(32)(33) Coleman et al (35) evaluated the efficacy of the ICT Malaria Pf/Pv in a large study of 559 asymptomatic patients from an endemic area of Thailand using conventional microscopy as the reference method, and found that the sensitivity for P. falciparum dropped from 100 to 23.3% when the parasitemia was below 500 trophozoites/µL. For P. vivax infections, the sensitivity dropped from 66.7% to 0 at parasitemia below 500 trophozoites/µL.…”
Section: Discussionmentioning
confidence: 55%
“…A positive case of P. falciparum infection was defined as a patient with acute febrile illness accompanied by positive peripheral smear/ bone marrow examination and/ or a febrile patient with strong clinical suspicion of malarial infection, a positive Parasight-F test along with dramatic improvement when treated with standard antimalarial therapy, and exclusion of other etiological agents by appropriate investigations. The latter assumption is based on the very high specificity of the Parasight-F test in detecting P. falciparum cases, as shown by various clinical trials and field studies [4][5][6][7][9][10][11]. Also, It has been postulated and argued by several researchers that the Parasight-F test can be positive in a proportion of severe and complicated cases of patient infection with P. falciparum, who may be aparasitemic by the time they are admitted to a hospital, due to inadequate antimalarial treatment or low grade chloroquine resistance, resulting in negative smears.…”
Section: Methodsmentioning
confidence: 99%
“…This antigen is secreted early during the erythrocytic cycle of the parasite, with a peak during schizont rupture. Various clinical trials done to evaluate the diagnostic sensitivity and specificity of this test have shown a sensitivity varying from 86.7% to 93.4% and a specificity of from 98.2% to 99.3% [4,5,6]. In India, Pinto et al have reported that this technique can be superior to peripheral smear staining and helps in making an early diagnosis [7].…”
mentioning
confidence: 99%
“…The OptiMAL test was run with 127 samples. Among 57 samples positive by microscopy, eight were negative (9,13,42,8,80,32,16, and 16 parasites/l, respectively) and one showed a non-distinct pattern (144 parasites/l) (84% sensitive). Among 70 samples negative by microscopy, none were positive by the OptiMAL test (100% specific).…”
Section: Assay Format and Characteristicsmentioning
confidence: 99%
“…The antigenic activity of HRP-2 has also been found to persist in the blood stream long after a malarial episode has been resolved by antimalarial therapy. 8,9 The possibility that HRP-2 persists after infection would negate the possibility of using HRP-2-based assays for monitoring anti-malarial therapy and detecting drug-resistant infections.…”
mentioning
confidence: 99%